The Biden administration last week call on healthcare providers once more to use monoclonal antibody treatments on those at high risk of suffering severe illness from the COVID-19 virus.

Heparin-induced thrombocytopenia (HIT) is a serious immune-mediated adverse effect of heparin therapy, characterised by ...

Invivyd began life as Adagio Therapeutics. Spun off of Adimab in mid-2020, the start-up had a lofty goal of creating ...

How monoclonal antibodies work against omicron variant The race is on for new treatments that stand up to omicron's explosive spread.

Monoclonal antibodies are the building blocks of some of the most important medical treatments in the world. For example, the large size of the molecules mean monoclonal antibody treatments ...

Researchers at McMaster University have discovered that a rare but dangerous reaction to a widely used blood thinner is ...

While common sense may suggest that antibodies that do not neutralize the SARS-CoV-2 virus are of little value, recent studies show they can still confer protection against infection. Monoclonal ...

Revolutionary advancements in monoclonal antibodies are considered for prevention of RSV.

Adam C. Welch, PharmD, MBA, FAPhA: So if these monoclonal antibodies are relatively short as far as the duration of protection that they provide and we’re not quite sure when the RSV ...

This monoclonal antibody from AstraZeneca/Sanofi could be crucial to protect babies born long before the RSV season, making the potential maternal vaccine less useful.

Netherlands-based biotech Citryll has dosed the first subject in the randomised Phase IIa trial, Citydream, assessing its ...